Skip to main content
I

INOVIQ LTD — Investor Relations & Filings

Ticker · IIQ ISIN · AU0000196149 ASX Professional, scientific and technical activities
Filings indexed 855 across all filing types
Latest filing 2025-10-12 Regulatory Filings
Country AU Australia
Listing ASX IIQ

About INOVIQ LTD

https://www.inoviq.com

INOVIQ LTD specializes in the development and commercialization of next-generation exosome and precision diagnostics. The company focuses on innovative solutions for the early detection and monitoring of cancer and other diseases. Its proprietary technology portfolio includes EXO-NET, a high-throughput exosome capture tool designed for research and clinical applications, and the SubB2M platform, which utilizes an engineered protein to detect the pan-cancer biomarker Neu5Gc. The company also provides the hTERT test for bladder cancer monitoring. These technologies facilitate non-invasive liquid biopsy tests aimed at improving patient outcomes through high sensitivity and specificity. The core business activities encompass the creation of diagnostic tools and research reagents for the global healthcare and life sciences sectors, emphasizing precision medicine and early intervention.

Recent filings

Filing Released Lang Actions
Investor Presentation 56 pages 3.6MB
Regulatory Filings
2025-10-12 English
Proposed issue of securities - IIQ 9 pages 29.3KB
Regulatory Filings
2025-10-12 English
Update - Proposed issue of securities - IIQ 9 pages 28.8KB
Regulatory Filings
2025-10-12 English
Trading Halt 2 pages 258.5KB
Regulatory Filings
2025-10-08 English
Board nomination closing date 1 page 224.7KB
Regulatory Filings
2025-10-01 English
CAR-T exosome data published 2 pages 307.9KB
Regulatory Filings
2025-09-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.